GlassScriptPhysician profile
David Deaton
NPI 1023000858
$608,955.38
in general payments reported to CMS, 2019-2025
16 companies · $1,031 in 2025
The $1,031 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $116K · 2021: $240K · 2022: $28K · 2023: $170K · 2024: $25K · 2025: $1,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $125K · Acquisitions: $57K · Travel and Lodging: $6,303 · Honoraria: $5,200 · Food and Beverage: $2,260 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $124,581.63 |
| Acquisitions | $56,821.00 |
| Travel and Lodging | $6,302.98 |
| Honoraria | $5,200.00 |
| Food and Beverage | $2,260.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Devoro Medical INC. | $328,924.88 | 2020-2021 | |
| Limflow INC. | $158,617.20 | 2023 | Limflow System |
| Elucid Bioimaging INC | $28,725.13 | 2021-2022 | |
| Inari Medical, INC. | $24,204.87 | 2024 | Limflow System, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Intact Vascular, INC. | $23,549.31 | 2019 | |
| Medtronic Vascular, INC. | $21,070.59 | 2019-2020 | |
| Boston Scientific Corporation | $8,924.83 | 2022-2025 | Arterial Wolf, Enroute Transcarotid Neuroprotection System |
| Philips North America LLC | $7,621.06 | 2019-2025 | (6554) Periph Vasc Undiv, (5028) Igt Devices Systems Undivided, Igt Devices Systems Undivided |
| Endologix LLC | $6,051.72 | 2019-2025 | |
| Silk Road Medical, INC. | $503.08 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $239.41 | 2019-2024 | Profusion Therapeutic Infusion Needle, Cook |
| Medtronic, INC. | $200.59 | 2021-2022 | |
| Bolton Medical INC | $164.07 | 2024 | Treo Abdominal Stent-Graft System |
| Janssen Pharmaceuticals, INC | $107.10 | 2021 | |
| Siemens Medical Solutions USA, INC. | $36.50 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $15.04 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$113,642.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Deaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.